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Abstract  
The liver stem cell niche is a specialized and dynamic microenvironment with biomechanical 
and biochemical characteristics that regulate stem cell behavior. This is feasible due to the 
coordination of a complex network of secreted factors, small molecules, neural, blood 
inputs and extracellular matrix (ECM) components involved in the regulation of stem cell 
fate (self-renewal, survival, and differentiation into more mature phenotypes like 
hepatocytes and cholangiocytes). 
In this review, we describe and summarize all the major components that play essential 
roles in the liver stem cell niche, in particular, growth factor signaling and the biomechanical 
properties of the ECM.  
 
 
Keywords: liver development, ECM, stem cell, progenitor cell, stem cell niche, growth 
factors, mechanobiology 
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1. Introduction  
The stem cell niche is a specific and dynamic microenvironment in which many inputs such 
as signals departing from blood vessels, neural and supportive cells, as well as secreted 
factors, and extracellular matrix (ECM) components regulate stem cell behavior. These 
multiple signals with a physical, electrical, structural or biochemical nature are responsible 
for supporting stem cell properties. 
In the last two decades, the role and importance of the ECM in cell biology has considerably 
increased, and currently, the ECM is recognized as an active entity composed of a variety of 
proteins and other molecules(Akhmanova et al., 2015). Besides, the structural, chemical and 
functional diversity of ECM components confers distinct biomechanical and biochemical 
properties to the ECM, providing a specific composition to the matrix, strictly correlated 
with the tissue, and sometimes species, of origin. In the liver, the extrahepatic stem cell 
niches are located in the peripheral or peribiliary glands inside the walls of the bile ducts, 
while the intrahepatic stem cell niches are found on the ductal plates of fetal livers and the 
Canals of Hering in the postnatal livers (Schmelzer et al., 2007). Although the major 
structural components of liver’s ECM are collagens (COL) and fibronectin (FN), the matrix of 
bile ductules, where the progenitor cells reside, is mainly composed of COL IV and laminin 
(LN) (Terada and Nakanuma, 1994; Yasoshima et al., 2000). 
The liver is known for its unique regenerative capability. The support of stem cell behavior 
provided by the stem cell niche helps maintain their quiescent state in homeostasis and 
regulates their self-renewal, expansion, and differentiation after activation. Following tissue 
injury, the surrounding microenvironment promotes self-renewal and differentiation of 
stem cells by activating and sending numerous signals. Moreover, the secretion of diverse 
growth factors (GF) such as TGF-α, EGF, FGF, and HGF play an essential role in liver 
development, health, and disease. The ECM is also a reservoir of GF and bioactive molecules 
by regulating their diffusion and availability (Hynes, 2009; Wilgus, 2012). It is constituted by 
adhesive molecules, notch signaling proteins, and proteoglycans which can bind and 
modulate GF activity (Lee et al., 2011).  
Several authors have tried to determine which factors, signals or conditions control the fate 
choice of hepatic stem/progenitor cells to differentiate towards a specific cell type. This 
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review provides an in-depth summary of the most recent findings on the role of hepatic 
ECM in liver stem cell behavior. 
2. Composition and function of stem cell niches in solid organs 
In 1978, Raymond Schofield proposed that stem cells resided in specific locations called 
niches, which provided a complex multifactorial microenvironment (Schofield, 1978). Today, 
we can determine that a stem cell niche is an accurate and complex microenvironment 
within a specific anatomic location. It comprises cellular and acellular elements that interact 
with local and systemic signals for the regulation of the stem cell function (Kordes and 
Haussinger, 2013; Mohyeldin et al., 2010; Scadden, 2006), where the interactions of 
neighbors with stem cells via cadherins (Marthiens et al., 2010) and soluble paracrine signals 
play a critical role for stem cell maintenance and differentiation. Thus, the niche is not 
merely the place where stem cells reside, but it also compromises the microenvironment 
generated by the surrounding cells, involving the release of signals that induce stem cell 
quiescence. It also promotes stem cell asymmetric and symmetric divisions critical in tissue 
homeostasis, regeneration and repair, and ultimately the anchorage of stem cells and 
stromal cells to the ECM (Jones and Wagers, 2008). Although in vivo stem cell 
microenvironments are entirely inaccessible, it is usually regarded that the presence of a 
stem cell defines a genuine stem cell niche. Thus, despite the importance of all niche 
elements, the identification of a stem cell is the necessary evidence (Weissman, 2000). 
Stem cells are frequently found on basement membranes (Fuchs et al., 2004), where 
specific adhesion molecules called integrins mediate the interactions. Alteration or loss of 
integrin expression gives rise to the recruitment of stem cells (Watt and Hogan, 2000). 
Additionally, the direct contact with peripheral nervous system elements helps to control 
stem cell recruitment. 
A typical stem cell niche includes different components that are perfectly integrated and 
controlled. These components comprise the mentioned stem cells, stromal cells, ECM 
proteins, soluble factors, and innervation and neural inputs (Fig. 1). Other key niche factors 
are cell-cell and cell-ECM adhesions, as mentioned above. Although these are standard 
components, every particular tissue sustains different functional and specialized types of 
niches (Jones and Wagers, 2008). Mohyeldin et al. suggest that oxygen and other gaseous 
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messengers can also be considered as components of the stem cell niche, in the sense that 
they can also act as metabolic regulators of stem cell function (Mohyeldin et al., 2010). 
3. Liver development 
Hepatic development and organization begins by the third week of gestation and continues 
until the postnatal stage. The anterior portion of the hepatic diverticulum forms the 
intrahepatic biliary tree and the liver, whereas the posterior portion gives rise to the 
extrahepatic bile ducts and the gallbladder (Zorn, 2008). 
From definitive endoderm, hepatocytes are originated during embryonic development after 
hepatic competence acquisition by ventral foregut endoderm and specification of those 
epithelial cells into hepatic endoderm (Zaret, 2008, 2016). 
Primordial liver cells transition into a non-polarized cellular phenotype called hepatoblasts, 
which then generate the liver bud. These cells are bipotent progenitor cells that express 
fetal hepatic genes as well as cholangiocyte and hepatocyte lineage genes (Schmelzer et al., 
2007). They can differentiate into both cell types depending on different signaling pathways. 
Notch and TGF-β promote biliary differentiation (Clotman et al., 2005; Decaens et al., 2008; 
Tanimizu and Miyajima, 2004). However, the specification of hepatoblasts toward 
hepatocyte fate is promoted when these pathways are down-regulated (Huch et al., 2013; 
Huch et al., 2015; Nantasanti et al., 2015). 
4. Liver stem cell niches 
The human hepatic stem cells are located in the ductal plates of the fetal and neonatal 
livers, and in the Canals of Hering in pediatric and adult livers (Kordes and Haussinger, 2013; 
Kuwahara et al., 2008; Saxena and Theise, 2004; Schmelzer et al., 2007; Stachelscheid et al., 
2009; Zhang et al., 2008; Zhou et al., 2007). These cells constitute approximately 0.5-2% of 
the parenchyma and have a size that ranges between 7-10 μm in diameter with a high 
nuclear-cytoplasm ratio. They express EpCAM, NCAM, CD133, CXCR4, SOX9, SOX17, FOXA2, 
CK8/18/19, Hedgehog protein, Claudin 3, and ALB at deficient levels. They do not express 
AFP, ICAM-1 or endothelial, mesenchymal, and hematopoietic markers(Schmelzer et al., 
2007). 
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The hepatoblasts reside mainly in the parenchyma of fetal and neonatal livers or as small 
aggregates in the Canals of Hering in adult livers (Zhang et al., 2008). These progenitor cells 
have a larger size than the hepatic stem cells (10-12 μm), as well as more substantial 
amount of cytoplasm; however, they have an overlapping antigenic profile (Schmelzer et al., 
2006; Schmelzer et al., 2007; Theise et al., 1999). They share the expression of CXCR4, 
CD133, SOX17, CK8/18/19, Hedgehog proteins and the non-expression of hematopoietic, 
endothelial or mesenchymal markers. The differences are found in the reduction of the 
expression levels of EpCAM, in the presence of high levels of ALB with discrete cytoplasmic 
packing, the change of expression of NCAM by ICAM-1, and a strong expression of AFP, 
amongst others. The percentage of these cells in postnatal livers decreases to <0.01% of 
parenchymal cells (Schmelzer et al., 2007; Zhang et al., 2008). On the contrary, they 
undergo a significant expansion during specific regenerative processes associated with 
several diseases such as cirrhosis and toxic injury. 
In the past decade, other niches of stem cells have been identified in the large intrahepatic 
bile ducts, which have a distinct histology, resembling the one found in the extrahepatic bile 
ducts (Cardinale et al., 2011; Carpino et al., 2012). This is a different stem cell niche located 
in the peribiliary glands, which contain a different stem cell population known as human 
biliary tree stem/progenitor cells (hBTSCs), which can be differentiated into cholangiocytes 
and hepatocytes (Reid, 2016; Semeraro et al., 2012). hBTSCs originated from the common 
bile duct are also amenable to be differentiated into pancreatic cell lineages (Cardinale et 
al., 2015; Wang et al., 2013), displaying the nature of a multipotent stem cell. 
 
5. Role of liver ECM in the liver stem cell niche 
5.1. The interaction between ECM and hepatic stem cells  
The process of ECM renovation is a complex but remarkably synchronized procedure 
resulting from the equilibrium among production, secretion, degradation (Lu et al., 2011). 
Although ECM comprises less than 3% in a healthy liver section (Gressner, 1992), and minimal 
modification on the ECM has a direct consequence in hepatic functions (Bedossa and 
Paradis, 2003). 
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The principal structural components of the liver ECM are COL and FN. COL I and III are 
expressed in the portal stroma, space of Disse, liver capsule, and fibroid tissue (Aycock and 
Seyer, 1989; Martinez-Hernandez, 1984). COL IV and LN give rise to the basal lamina of 
the blood vessels and bile ducts (Martinez-Hernandez, 1984). COL V forms thin fibers 
located in the center of thick COL I and III fibrils. On the other hand, FN is a glycoprotein 
that can be found in the liver capsule, portal stroma, and space of Disse. FN levels 
increase during liver regeneration (Aziz-Seible and Casey, 2011), while the absence of 
that is correlated with cirrhosis, liver stiffness, and disorganized COL network (Iwasaki et 
al., 2016). Cell-cell interaction and also cell-matrix interplay are essential in the regulation 
of the stem cell behavior within niches (Spradling et al., 2001). In the liver, the ECM and 
basement membrane of bile ducts, where the progenitor cells reside, are mainly composed 
of COL IV and LN (Terada and Nakanuma, 1994; Yasoshima et al., 2000). 
It is known that the liver has a significant regenerative ability. Although hepatocytes have a 
slow turn-over, hepatic injury promotes a rapid reconstitution of liver mass, where 
inflammatory cytokines such as TNF-α and IL-6 produced by Kupffer cells (Kwon et al., 2015) 
trigger hepatocytes to enter the cell cycle (G0 → G1). As hepatocyte proliferation is 
overwhelmed by some drugs, toxins or in chronic liver diseases, liver stem/progenitor cells 
contribute to liver regeneration (Roskams et al., 2003; Vig et al., 2006). However, little is 
known about the surrounding environment of the hepatic progenitor cells. Different hepatic 
chronic diseases are characterized by excessive deposition of ECM because of continuous 
liver damage. Murata et al. demonstrated that fibrotic livers have more than five-fold 
increase in COL deposition compared to a healthy organ (Murata et al., 1984). 
Stuart Forbes’ research group demonstrated that during liver damage, both in rodents and 
humans, there are specialized niches around hepatic progenitors where the LN helps the 
maintenance of undifferentiated progenitor cells (Lorenzini et al., 2010). Furthermore, LN 
also promoted the expression of biliary/hepatoblast genes and significantly inhibited the 
expression of early hepatocyte genes, demonstrating the role of this protein in the control 
of liver progenitor cell fates (Lorenzini et al., 2010). Studying the expansion of liver 
progenitor cells in a choline-deficient ethionine-supplemented model, it was observed that 
the deposition of ECM precedes the expansion and migration of the progenitor cells (Van 
Hul et al., 2009). This accumulation of COL I and LN was found in front of these progenitor 
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cells along the portal-venous gradient of lobular invasion(Van Hul et al., 2009). Therefore, 
changes in the ECM composition alter the cell signaling in liver, facilitating either normal 
regeneration or paving the way for liver disease (Williams et al., 2014). Recently, Klaas et al. 
studied the role of the ECM in liver regeneration (Klaas et al., 2016). They observed 
considerable alterations (COL, FN, and elastin) as well as in non-structural proteins. These 
changes resulted in the rearrangement and increase of the stiffness in damaged liver ECM 
(Klaas et al., 2016). Takayama et al. succeeded to culture and expand pluripotent stem cell-
derived hepatoblasts on dishes coated with human LN-111. These cells were maintained for 
more than three months and could differentiate into both hepatocyte-like cells and 
cholangiocyte-like cells (Takayama et al., 2013). 
5.2. Growth factor presentation  
GF are key intercellular signaling molecules (mostly proteins) that direct cells during 
development and adult organisms, controlling cell growth, migration, and differentiation 
(Lee et al., 2011). 
Many GF and small molecules play critical roles in the hepatic specification and stem cell 
maturation (Chen et al., 2018). TGF-α and EGF are just a few examples of liver autocrine GF 
signaling. They are produced both by hepatocytes and non-parenchymal cells, and 
concentration gradients of these molecules induce different liver cell behaviors. In the case 
of HGF, it can cause hepatocyte loss, leading to an embryonic liver size reduction (Schmidt 
et al., 1995). FGF also plays an essential role in liver development, health and disease. Itoh 
et al. concluded that these molecules could work at the paracrine and endocrine level (Itoh 
et al., 2016). Examples of FGF as paracrine factors are FGF8 and FGF10, involved in 
embryonic liver development; FGF7 and FGF9, in tissue repair after liver injury, and FGF5, 
FGF8, FGF9 in the development and progression of hepatocellular carcinoma. 
On the other hand, FGF15/19 and FGF21 are endocrine signals that play critical roles in the 
bile acid metabolism. Insulin is also known by preserving many hepatocyte-specific 
functions, like albumin secretion by hepatocytes, lipogenesis, and glycogenesis, amongst 
others. OSM is an interleukin family cytokine involved in hepatic maturation and the 
induction of hepatocyte-specific functions such as lipid synthesis, detoxification, and 
ammonia clearance. However, it has also been shown that progenitor cells that receive OSM 
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do not mature, despite stimulating hepatocyte differentiation. Interestingly, hepatocyte 
function is recovered when OSM is removed from the environment (Levy et al., 2015). 
The ECM can additionally be considered as a reservoir of GF and bioactive molecules, 
regulating their diffusion (Hynes, 2009; Wilgus, 2012). It contains many components like 
adhesive proteins, notch signaling molecules, and proteoglycans which can bind and 
modulate GF activity (Lee et al., 2011). In other cases, GF can be released through ECM and 
proteoglycan degradation. Furthermore, the ECM can storage immature molecules until 
they are activated. For example, TGFβ, which stimulates biliary differentiation, is secreted in 
an inactivated way and remains retained in the ECM until its activation (Yue, 2014). 
Downregulation of this signaling pathway allows hepatoblasts to differentiate into 
hepatocytes (Huch et al., 2015) (Fig. 2). Additionally, some GF contain heparin-binding 
domains (HBD), which are critical for the modulation of biological activities like cell 
proliferation, differentiation, morphogenesis, and angiogenesis. The first growth factors 
isolated with this motif were bFGF (FGF2) (Bohlen et al., 1984) and aFGF (FGF1) (Bohlen et 
al., 1985). Since then, a vast family of GFs containing an HBD was identified (e.g., VEGF, 
PDGF, EGF, other FGFs, TGFbetc) (Rider and Mulloy, 2017). 
Proteoglycans are proteins that carry glycosaminoglycans (GAGs), a vital carbohydrate that 
exists in four forms in the liver and in different quantities: heparan sulfate, chondroitin 
sulfate, dermatan sulfate, and hyaluronic acid (Baghy et al., 2016; Kjellen and Lindahl, 1991). 
Complexes formed between GAGs and GFs, like FGF-heparin or FGF-heparan sulfate 
complexes, protect the GFs from degradation. Furthermore, heparan sulfate plays key roles 
in binding and interacting with GF, plasma proteins, and other factors, allowing with this, 
the regulation of protein distribution, bio-availability, and action to target cells. Even though 
there are well-known signaling proteins that interact with heparan sulfate domains, there 
are still knowledge gaps that remain to be elucidated (Billings and Pacifici, 2015).  
All these mechanisms act on stem cells and stem cell niches, modulating stem cell 
proliferation and differentiation. 
5.3. Mechanobiology of ECM and liver Stem Cells. 
In the last years, the field of biomedical engineering has continuously evolved. This progress 
has introduced new relevant knowledge, as the concept of mechanobiology. 
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Mechanobiology is a scientific area at the interface of the biology and engineering, focused 
on the study of the role that tissue biophysical stimulus and mechanical environment (force, 
geometry, topography, stiffness, matrix elasticity) play in cellular processes, including 
differentiation, injury response, physiology, and pathology (Engler et al., 2006; Ingber, 
2018). Consequently, mechanobiology identifies that cells can recognize not only 
biochemical signals, but also physical factors that impact their normal functioning and 
maintenance (Lim et al., 2010). 
Currently, it is well documented that all the cells in the body are mechanosensitive (Jaalouk 
and Lammerding, 2009), including liver cells. This organ was not considered to be associated 
with a mechanical load in the past. Hence, liver mechanobiology represents a field in 
progress that might be critical in areas such as development, pathology, and tissue 
engineering. In this section, we sought to provide a thorough description of hepatic 
mechanobiology and ECM contribution. 
An essential component of cellular mechanosensitivity is the capability of the cell-cell and 
cell-matrix interactions to detect and respond to the mechanical stiffness of its surface. The 
focal adhesion complexes are the points where cell-matrix interactions take place, mediated 
by integrin molecules that link the ECM to the actin-myosin cytoskeleton of the cell. The 
contraction promoted by the complex actin-myosin cytoskeleton allows the cell to survey its 
mechanical environment through the movement of the integrin. In general, when the ECM 
is stiff, the contraction of the cellular cytoskeleton is more difficult, and it generates an 
accumulation of integrins, enlarged focal adhesions, and further development of the 
cytoskeleton (Janmey and Miller, 2011). The integrin movement is a downstream signaling 
pathway where the Rho/GTPases and the contraction of the actin-myosin cytoskeleton 
(Wells, 2008a) are the primary mediators. Cell-cell interactions are mediated via cadherins, 
creating a bridge between the cytoskeleton of two neighboring cells (Smutny and Yap, 
2010). Taking into account this premise, the optimal stiffness for culturing and expanding 
any given cell type corresponds to the in vivo elastic modulus of its corresponding tissue 
(Pedro M.Baptista, 2014). Sometimes, the stiffness of a tissue or a substrate is defined 
regarding Elastic or Young's modulus, a constant that refers to the ability of a material to 
resist a determined deformation, or the ratio of strain when stress is applied. The liver, 
which is a soft organ, is described as viscoelastic with a non-linear stress-strain behavior 
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(Suh and DiSilvestro, 1999). The effects of these ECM properties on cell mechanosensitivity 
are mostly unknown (Pedro M.Baptista, 2014). 
The chemical structure of a tissue and the organization of all its components, as COL, 
proteoglycans, and FN amongst others contribute to mechanical strength and behavior of 
the tissue. Consequently, modifications produced in any of these components, lead to 
alterations in the mechanical properties of the tissue (Wells, 2008c). The human liver is 
composed by a population of stem/progenitor cells located in the stem cell niche. The 
components of the ECM in the liver stem cell niche are exclusive when compared with the 
rest of the liver, and therefore, the mechanical properties or stiffness of these regions are 
different from the rest of the organ (Lozoya et al., 2011). An excellent example of 
mechanically controlled cell response is the human hepatic stem cells that can differentiate 
into hepatocytes on soft surfaces, while cholangiocytes are observed on more rigid surfaces 
(LeCluyse et al., 2012).  
In the liver, the property of stiffness is not static, and it fluctuates with organ development, 
disease, and repair. During early liver development, human progenitor stem cells in their 
undifferentiated state are maintained in the endoderm due to a low stiffness environment. 
The creation and development of ECM structures, cytokines, and environmental stimuli 
usually initiate cell migration and differentiation of human progenitor stem cells into more 
mature parenchymal liver cells (Si-Tayeb et al., 2010a; Si-Tayeb et al., 2010b). These 
determinations have been observed in vitro experiments, where the use of low stiffness 
substrates promoted the maintenance and expression of stem cell markers in human 
progenitor stem cells (Schrader et al., 2011). Similarly, in work performed by Lozoya et al. 
(Lozoya et al., 2011), human hepatic stem cells were cultivated in 6 different hydrogel 
formulations during one week and then, the degree of differentiation was analyzed by using 
various markers. The generated results demonstrated a stiffness-dependent behavior of 
these cells (Smutny and Yap, 2010), suggesting that cells seeded on their desirable 
mechanical environment allow to organize themselves in the same way observed in the 
stem cell niche.  
In mechanobiology, another significant stimulus is represented by the shear stress. Human 
liver stem, progenitor, and embryonic stem cells have been shown to differentiate into 
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mature liver cells when exposed to shear stress in perfusion bioreactor cultures (Miki et al., 
2011; Schmelzer et al., 2010). The work developed by Toshio et al. demonstrated the 
potential of using a four-compartment 3D perfusion culture to induce hepatic 
differentiation in embryonic stem cells. In this study, the hepatic differentiation was carried 
out by using a combination of cytokines with the culture in a dynamic 3D perfusion system. 
This study showed that the 3D perfusion culture induced more functional maturation in 
embryonic stem-derived hepatic cells, compared with 2D cultures and consequently, the 
use of 3D perfusion bioreactor technologies may be useful for further studies on generating 
embryonic stem cell-derived hepatic cells (Miki et al., 2011; Schmelzer et al., 2010). Finally, 
another type of mechanical force to consider in the liver is the interstitial fluid pressure, 
which hepatocytes are sensitive and able to respond to (Hsu et al., 2010).  
In the context of partial hepatectomy, the loss of tissue is completely regenerated de novo 
through hepatocyte proliferation and the activation of matrix-producing cells. Through 
regeneration, a provisional matrix is generated during the early stages, and it contains 
uncrosslinked COL I (T Kim, 2003). When regeneration is mediated by progenitor cells, the 
initial composition of the matrix maintains the hepatoblast phenotype until ECM structures 
are fully formed with the addition of COL IV and the crosslinking of COL I (Zhang et al., 
2008). If proliferating hepatocytes initiate the regeneration, the production of the matrix 
takes place by human hepatic stem cells simultaneously. In this process, physical and 
chemical cues provided by the ECM control the initiation and cessation of cell propagation 
(Kordes et al., 2014). Along the same line, alterations in this process produce an increase in 
stiffness and consequently, liver dysfunction, being the last one an essential parameter in 
the prognosis of liver diseases and hepatocellular carcinoma (Jung et al., 2011; Tsukuma et 
al., 1993). During the fibrotic state, the human hepatic stem cells are activated and an 
excess amount of LN and COL, especially COL IV, are deposited (Wells, 2008b).  
In summary, the correct interplay between the ECM biomechanical and biochemical 
environment is a crucial factor for liver stem/progenitor and more mature cells in 
homeostasis, development, regeneration, and disease. 
5.4. Novel tools for ECM – Stem Cell interaction research 
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Ideally, the best method to study and determine the interactions of ECM components with 
stem cells is within in vivo studies. However, these studies are difficult to perform due to the 
complexity of the stem cell niche and the strict legislation that controls the human/animal 
experimentation. Focused on animal experimentation, apart from ethical considerations, 
the work with animals is time consuming, laborious and expensive (Andersen and Winter, 
2017). These issues have forced researchers to find new alternatives to decrease the time 
and resources involved in these type of studies and, naturally, to decrease the number of 
animals used. The term 3R'S (reduction, refinement, and replacement), is an alternative 
strategy that was defined by Russell and Burch and that included a large variety of new 
techniques that intend to recreate the physiological environment found in vivo without the 
use of animals (Arora et al., 2011; Franco et al., 2018). 
An excellent example of this strategy is the work developed by M. Huch et al. in 2013 when 
they turned to 3D cell culture systems to investigate the stem cell biology of the liver. The 
structures generated in these culture systems were called organoids (Huch and Koo, 2015) 
and defined as a 3D structure derived from either pluripotent stem cells, neonatal tissue 
stem cells or adult-derived stem/progenitor cells. In these, cells spontaneously self-organize 
into structures that resemble the in vivo tissue concerning the cellular composition and 
tissue function (Hindley et al., 2016). In the publication mentioned above, researchers 
showed that the Wnt-target Lgr5 labels actively proliferating cells in the adult mouse liver 
following toxic damage. When these Lgr5 positive cells were expanded and self-organized 
into 3D cystic structures by using Matrigel® and by adding a chemically defined growth 
medium containing specific GF, these cells had the potential of differentiating into both 
hepatocytes and cholangiocytes in vivo (Huch et al., 2013). In 2015, by employing a similar 
strategy, this research group was able to establish human hepatic organoids from both 
healthy liver biopsies and single EpCAM positive cells (Huch et al., 2015). Hence, organoid 
cultures represent an ideal tool for studying stem cell niche interactions in a 3D ECM 
microenvironment, since this method is amenable to ECM manipulations that might shed 
some light in knowledge gaps of certain liver diseases and help translational medicine, by 
providing a more physiologically relevant 3D in vitro model system. 
Another tool that has attracted significant interest in the last decades is the use of 
tissue/organ decellularization. This process usually consists of the perfusion of a detergent 
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solution in order to remove cellular contents, preserving only the ECM of the organ. The 
decellularization method applied in human, porcine and rat liver ECM generated scaffolds 
containing the major proteins present in the liver ECM, like LN, COL, or FN, and also the 
ECM-bound GF. These properties improve the physiology of the in vitro microenvironment 
(Soto-Gutierrez et al., 2011; Wang et al., 2016). In a recent study, Vyas et al. showed that 
human fetal liver progenitor cells self-assembled inside acellular liver scaffold discs to then 
form 3D liver organoids, which were able to recapitulate several aspects of hepatobiliary 
organogenesis and resulted in the parallel formation of progressively more differentiated 
hepatocytes and bile duct structures. This model shows relevant information about 
mechanisms of hepatic and biliary development and could be an exciting model in the 
future of disease modeling and drug screening (Vyas et al., 2017). 
The link between biomedical engineering and biology has allowed the creation of a new 
alternative tool: Bioprinting. It consists in the use of spatial patterning of living cells and 
other non-living biologic materials employing an additive manufacturing technique (Ozbolat 
et al., 2016). This technique allows for the precise control of the microarchitecture and 
macroarchitecture of tissues and organs, which is critical to the function of many biological 
structures (Leberfinger et al., 2017). A clear example of this technology was reported 
recently by the group of Alan Faulkner-Jones et al. where these researchers reported the 
first investigation into the bioprinting of human pluripotent stem cells, their response to a 
valve-based printing process, as well as their post-printing differentiation into hepatocyte-
like cells. The hepatic-like cells were examined for the presence of hepatic markers to 
further validate the compatibility of the valve-based bioprinting process with fragile cell 
transfer (Faulkner-Jones et al., 2015). 
Throughout this section, we have described technologically sophisticated engineering tools 
that allow more precise control over the liver stem cell microenvironment, amenable to test 
the relevant role played by the use of decellularized ECM or its multiple components, as 
well as the use of specific GFs. These new tools have the potential to promote further 
advances in diverse areas such as the study of liver development, homeostasis, and disease, 
by recreating much more accurately the micro/macroenvironment found in vivo. 
6. Conclusion 
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It is well known that the liver is an organ with a remarkable regenerative capacity. Part of 
this regenerative ability is possible due to the synchronous proliferation of stem cells and 
ECM remodeling in the stem cell niche, which provides a complex multifactorial 
microenvironment where many inputs regulate stem/progenitor cell behavior. 
Traditionally, decades ago, the liver ECM was considered to be an inert cell growth 
substrate. However, due to the developments made in the last decades, it is now recognized 
that the liver ECM is a dynamic structure, which is composed of a variety of proteins and 
other macromolecules that work as a supportive scaffold, regulating cell biological 
functions. Finally, the ECM mechanobiology is also vital in the regulation of stem cell 
behavior, where cells can detect and identify physical factors. Therefore, the correct 
performance and maintenance between the biophysical, biomechanical and biochemical 
microenvironment of the ECM and liver stem cells are essential to direct stem and 
progenitor cell quiescence, proliferation, and differentiation, profoundly impacting organ 
homeostasis, repair, regeneration, and disease. 
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Figures and legends 
 
Figure 1: Stem cell niche components. Stem cell niches are specific microenvironments composed of multiple 
cells, such as neurons, stromal, epithelial, as well as blood vessels. Autocrine and paracrine signals mediate the 
interactions between all these componentssignals. Secreted molecules can also interact with cells which are 
not nearby, distributed via the bloodstream to different parts of the body. The ECM, which the main structural 
components are collagens and fibronectin, plays an essential role in the cellular niche functioning as a 
supportive scaffold that regulates the biological functions of the cells and it can be considered as a reservoir of 
growth factors and bioactive molecules, regulating their diffusion and availability. Here, it is also necessary to 
mention the role played by the mechanobiology, where physical signals are also critical for the correct ECM-
stem cell interaction. The stem cell niche maintains and controls the fate of the stem cells, supporting self-
renewal and maintaining the balance between quiescence, proliferation and differentiation. 
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Figure 2: Hepatic lineage. Different ECM components, growth factors, and signaling pathways are involved in 
the hepatic cell fate choice, as well as the location of the stem cells and hepatoblasts during human 
development. Laminin, collagen IV and heparin sulfate are ECM components involved in the stem cell self-
renewal. Heparin, proteoglycans, and fibronectin are necessary for stem cell differentiation into hepatoblasts. 
Laminin and collagen IV give rise to a cholangiocyte fate, whereas collagen I and fibronectin are responsible for 
hepatocyte differentiation. Hepatoblasts can differentiate into cholangiocytes and hepatocytes depending on 
different signaling pathways. Mainly, Notch, TGFB and Jagged promote biliary differentiation, meanwhile, 
Oncostatin M and HGF drive hepatocyte lineage. The primary markers that are specific of these cells are also 
described in brackets. 
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